Ngā hua rapu kaituhi :: APM

1

Microsatellite Instability in Colorectal Cancers: Carcinogenesis, Neo-Antigens, Immuno-Resistance and Emerging Therapies mā Violaine Randrian, Camille Evrard, David Tougeron

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

ABCB4/MDR3 gene mutations and cholangiocarcinomas mā David Tougeron, Ginette Fotsing, Véronique Barbu, Michel Beauchant

I whakaputaina 2012

Whiwhi kuputuhi katoa
Carta

Tiaki ki tētahi rārangi

I tiakina i:
3

Irreversible electroporation and electrochemotherapy in oncology: State of the art mā Jean‐Pierre Tasu, David Tougeron, Marie‐Pierre Rols

I whakaputaina 2022

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
4

Aspirin and Colorectal Cancer: Back to the Future mā David Tougeron, Dan Sha, Sashidhar Manthravadi, Frank A. Sinicrope

I whakaputaina 2013

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
5

Microsatellite Instability: Diagnosis, Heterogeneity, Discordance, and Clinical Impact in Colorectal Cancer mā Camille Evrard, Gaëlle Tachon, Violaine Randrian, Lucie Karayan‐Tapon, David Tougeron

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Beclin 1 and UVRAG Confer Protection from Radiation-Induced DNA Damage and Maintain Centrosome Stability in Colorectal Cancer Cells mā Jae Myung Park, David Tougeron, Shengbing Huang, Koichi Okamoto, Frank A. Sinicrope

I whakaputaina 2014

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment mā Julien Taı̈eb, Magali Svrcek, Romain Cohen, Debora Basile, David Tougeron, Jean-Marc Phélip

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer mā Marion Jeantet, David Tougeron, Gaëlle Tachon, Ulrich Cortes, Céline Archambaut, Gaëlle Fromont, Lucie Karayan‐Tapon

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer mā David Tougeron, F. Di Fiore, S. Thureau, N. Berbera, Isabelle Iwanicki–Caron, H. Hamidou, B Paillot, Pierre Michel

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Proof of concept and design of an externally controlled trial for patients with gastro-enteropancreatic neuroendocrine carcinomas based on the randomized phase II BEVANEC trial mā S. Ganame, T. Walter, A. Durand, Astrid Lièvre, David Tougeron, Jean–Yves Scoazec, E. Baudin, C. Lepage, Olayidé Boussari, Julien Hadoux

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
11

Second‐line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first‐line platinum‐b... mā Aziz Zaanan, Mélanie Gauthier, David Malka, Christophe Locher, Jean‐Marc Gornet, Anne Thirot‐Bidault, David Tougeron, Julien Taı̈eb, Franck Bonnetain, Thomas Aparicio

I whakaputaina 2010

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer mā David Tougeron, Thierry Lecomte, Jean‐Christophe Pagès, Claire Villalva, Christine Collin, Aurélie Ferru, J.M. Tourani, Christine Silvain, P. Levillain, L. Karayan-Tapon

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
13

Mutation‐specific antibody detects mutant BRAF<sup>V600E</sup> protein expression in human colon carcinomas mā Frank A. Sinicrope, Thomas C. Smyrk, David Tougeron, Stephen N. Thibodeau, Shalini Singh, Andrea Murányi, Kandavel Shanmugam, Thomas M. Grogan, Steven R. Alberts, Qian Shi

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
14

Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor mā Louis de Mestier, Thomas Walter, Camille Evrard, Paul de Boissieu, Olivia Hentic, Jérôme Cros, David Tougeron, Catherine Lombard‐Bohas, Vinciane Rebours, Pascal Hammel, Philippe Ruszniewski

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study mā Violaine Randrian, Amale Dhimene, Armelle Pillet, Camille Evrard, Rayan Elfadel, Claire Boyer, Astrid Guyot d’Asnières de Salins, Isabelle Ingrand, Aurélie Ferru, Laetitia Rouleau, David Tougeron

I whakaputaina 2025

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study mā Maëva Salimon, Caroline Prieux‐Klotz, David Tougeron, Vincent Hautefeuille, Morgane Caulet, Jérôme Gournay, Tamara Matysiak‐Budnik, Jaafar Bennouna, Manuela Tiako Meyo, Thierry Lecomte, Aziz Zaanan, Yann Touchefeu

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

“Decision for adjuvant treatment in stage II colon cancer based on circulating tumor DNA:The CIRCULATE-PRODIGE 70 trial” mā Julien Taı̈eb, Léonor Benhaïm, Pierre Laurent–Puig, Karine Le Malicot, Jean‐François Emile, Flore Geillon, David Tougeron, Sylvain Manfrédi, Marion Chauvenet, Valérie Taly, Côme Lepage, Thierry André

I whakaputaina 2020

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
18

Usefulness of the Serum Carcinoembryonic Antigen Kinetic for Chemotherapy Monitoring in Patients With Unresectable Metastasis of Colorectal Cancer mā Isabelle Iwanicki–Caron, Frédéric Di Fiore, Isabelle Roque, Emilie Astruc, Monica Stetiu, A. Duclos, David Tougeron, Sandrine Saillard, S. Thureau, Jacques Bénichou, B Paillot, J P Basuyau, Pierre Michel

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

<i>KRAS</i> Codon 12 and 13 Mutations in Relation to Disease-Free Survival in <i>BRAF</i>–Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance) mā Harry H. Yoon, David Tougeron, Qian Shi, Steven R. Alberts, Michelle R. Mahoney, Garth D. Nelson, Suresh Nair, Stephen N. Thibodeau, Richard M. Goldberg, Daniel J. Sargent, Frank A. Sinicrope

I whakaputaina 2014

Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
20

$Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program$

Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter stu... mā Antoine Adenis, Christelle de la Fouchardière, Bernard Paule, Pascal Burtin, David Tougeron, Jennifer Wallet, Louis-Marie Dourthe, Pierre-Luc Etienne, Laurent Mineur, Stéphanie Clisant, Jean-Marc Phélip, Andrew Kramar, Thierry André

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i: